Insight Molecular Diagnostics, Inc. (IMDX)
6.185
+0.62
(+11.24%)
USD |
NASDAQ |
May 20, 16:00
5.85
-0.34
(-5.42%)
After-Hours: 20:00
Insight Molecular Diagnostics Cash from Investing (Quarterly) : -0.613M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Veracyte, Inc. | -127.96M |
| Exagen, Inc. | -0.228M |
| bioAffinity Technologies, Inc. | -0.0057M |
| GRAIL, Inc. | -93.44M |
| FONAR Corp. | -0.173M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.639M |
| Cash from Financing (Quarterly) | 24.70M |
| Free Cash Flow | -27.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2391 |
| Free Cash Flow to Equity (Quarterly) | -7.824M |
| Free Cash Flow to Firm (Quarterly) | -8.229M |
| Free Cash Flow Yield | -13.59% |